BIOPOLUS - HUNGARY

OVERVIEW

Globally, more than 50% of the population lives in urban areas, and by 2045, this is estimated to increase by 1.5 times, to 6 billion. This unrivaled explosion in urbanization requires a paradigm shift from the current flow-through, linear phenomenon of resource inputs, processing, and its associated waste to a more cyclical structure that reduces resource consumption and waste production simultaneously.

Urban circularity, however, cannot exist without first achieving a sustainable water cycle, where residents have continuous access to safe clean water within the boundaries of their city. Via MNR technology, Biopolus has created a modular, expandable water treatment system for complex circular urban water treatment and management. By means of advanced metabolic engineering, energy, organic materials, and minerals can be derived from organic waste through biosolid fractionation. These solutions, along with optional space for community functions and urban food production are integrated and housed in the Biopolus BioMakery.

TECHNOLOGY

We are TECHNOLOGY PROVIDERS, serving clients through local partners and providing support throughout the project lifecycle. Our activities include:

1: FEASIBILITY: Concept Design
2: DESIGN: Process Design, Basic Mechanical & Electrical Design, Control & Instrumentation, Architectural Concept
3: CONSTRUCTION: Specialized Equipment (biofilm carriers, control & instrumentation, etc.)
4: STARTUP: Commissioning
5: OPERATION: Remote Supervision, Technology Support

The Metabolic Network Reactor (MNR) technology is Biopolus’ patented 3rd generation Integrated Fixed-film Activated Sludge (IFAS) water treatment technology. 

The underlying principle behind the MNR technology is a well-known natural phenomenon, where microbial biofilm develops on the roots of aquatic plants. The technology is characterized by a large quantity of biomass that is attached to submerged „carriers” – either to the natural root system of specially selected plants, or to artificial roots, developed by Biopolus, for this specific purpose.